Quantum Biopharma Ltd. Class B Subordinate Voting Shares (QNTM) Stock Price

QNTMStock

$3.28−89.68%52W

Market Cap$21.09M

P/E—

PEG Ratio—

Div yield—

Beta5.36

QNTM Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-16.99%

Price vs S&P 500 (4W)13.90%

VGM Score52.68

Book Value / Share (Quarterly)$0.10

Cash Flow / Share (Quarterly)$-0.96

Price vs S&P 500 (YTD)-67.32%

Net Profit Margin (TTM)-9078.87%

EPS (TTM)$-8.27

10-Day Avg Trading Volume0.01M

EPS Excl Extra (TTM)$-8.27

EPS (Annual)$-7.97

ROI (Annual)-76.01%

Gross Margin (Annual)-641.58%

Cash / Share (Quarterly)$1.71

ROA (Last FY)-61.46%

Revenue Growth TTM (YoY)236.06%

EBITD / Share (TTM)$-4.44

ROE (5Y Avg)-75.83%

Operating Margin (TTM)-5052.26%

Cash Flow / Share (Annual)$-48.45

P/B Ratio37.02x

P/B Ratio (Quarterly)31.16x

Net Income / Employee (Annual)$-2,617,500

Net Interest Coverage (TTM)-1.13x

ROA (TTM)-224.42%

EPS Incl Extra (Annual)$-7.97

Current Ratio (Annual)2.28x

Quick Ratio (Quarterly)0.63x

3-Month Avg Trading Volume0.01M

52-Week Price Return-89.68%

Revenue / Employee (TTM)$16,600

Tangible BV / Share (Quarterly)$0.62

P/S Ratio (Annual)112.88x

Asset Turnover (Annual)0.00x

52-Week High$28.59

EPS Excl Extra (Annual)$-7.97

26-Week Price Return-4.86%

Quick Ratio (Annual)2.22x

13-Week Price Return-57.12%

Total Debt / Equity (Annual)0.02x

Current Ratio (Quarterly)0.63x

Enterprise Value$18.56M

Asset Turnover (TTM)0.00x

Revenue / Employee (Annual)$19,500

Pretax Margin (Annual)-19353.53%

Cash / Share (Annual)$28.71

3-Month Return Std Dev119.96%

Net Income / Employee (TTM)$-3,115,900

ROE (Last FY)-77.29%

Net Interest Coverage (Annual)-0.88x

EPS Basic Excl Extra (Annual)$-7.97

Receivables Turnover (TTM)0.20x

Total Debt / Equity (Quarterly)1.46x

EPS Incl Extra (TTM)$-8.27

ROI (TTM)-453.15%

P/S Ratio (TTM)132.69x

Revenue / Share (Annual)$1.80

Price vs S&P 500 (52W)-111.88%

Year-to-Date Return-55.24%

5-Day Price Return-9.62%

EPS Normalized (Annual)$-7.97

ROA (5Y Avg)-64.82%

Net Profit Margin (Annual)-19353.53%

Month-to-Date Return15.76%

EBITD / Share (Annual)$-4.93

Operating Margin (Annual)-13644.50%

ROI (5Y Avg)-74.32%

EPS Basic Excl Extra (TTM)$-8.27

P/TBV (Quarterly)11.09x

Inventory Turnover (TTM)4.70x

Pretax Margin (TTM)-9078.87%

Price vs S&P 500 (13W)-60.42%

Beta5.36x

Revenue / Share (TTM)$0.02

ROE (TTM)-625.19%

52-Week Low$2.85

gGradeA

mGradeF

vgmGradeC

QNTM Earnings Surprise History

Q3 25-1.77est. -3.70

Q1 26-4.17est. -0.68

QNTM Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.14

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
QNTMQuantum Biopharma Ltd. Class B Subordinate Voting Shares	—	A	F	$3.28
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80

About Quantum Biopharma Ltd. Class B Subordinate Voting Shares

Quantum BioPharma is a biopharmaceutical company developing treatments for neurodegenerative and metabolic disorders, as well as alcohol misuse disorders. Its lead asset, Lucid-MS, is a patented therapeutic in preclinical development designed to prevent and reverse myelin degradation in multiple sclerosis. The company also maintains a portfolio of property-backed loans through a wholly owned subsidiary.